BG Medicine Announces Exercise of Underwriters’ Over-Allotment Option and Closing of Initial Public Offering

Published: Feb 10, 2011

WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine (NASDAQ: BGMD) today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares of BG Medicine’s common stock at $7.00 per share, less underwriting discounts and commissions. BG Medicine also announced that it has closed its initial public offering of 5,750,000 shares of common stock at a public offering price of $7.00 per share, which included the sale of the shares pursuant to the over-allotment option.

Back to news